A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Plaque Psoriasis
Related studies linked through entity extraction aliases.
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)
- Status
- COMPLETED
- Phase
- PHASE3
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
- Status
- COMPLETED
- Phase
- PHASE3
Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee Joint
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis
- Status
- RECRUITING
- Phase
- N/A
Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®
- Status
- RECRUITING
- Phase
- PHASE3
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
- Status
- RECRUITING
- Phase
- N/A
The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India
- Status
- COMPLETED
- Phase
- PHASE4
Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
- Status
- COMPLETED
- Phase
- N/A